ACM Global
ACM Global Laboratories is a privately held, US-headquartered central laboratory founded in 1975, providing customized clinical trial testing, bioanalytical, and toxicology (DRUGSCAN) services to pharmaceutical and biotech sponsors across 65+ countries.
- Company typePrivate
- Founded1975
- HeadquartersRochester, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What ACM Global does
ACM Global Laboratories (legal entity ACM Medical Laboratory, Inc. dba ACM Global Laboratories) is a privately held, US-domiciled clinical trial central laboratory founded in 1975 and headquartered in Rochester, New York, with 501–1000 employees and an affiliation with Rochester Regional Health. The company provides central laboratory testing services to pharmaceutical and biotechnology sponsors running clinical trials in 65+ countries, supported by wholly-owned facilities in Rochester (US), York (UK), Singapore, and Mumbai (India), plus a partner laboratory network. Its service portfolio is organized into three lines: Bioanalytical Services (PK bioanalysis, large molecule bioanalysis, pharmacodynamic biomarker analysis, controlled substance analysis, novel drug delivery systems, nicotine research, cannabinoid testing), Central Lab Services (clinical trial testing, biomarker testing, flow cytometry, radiopharmaceutical, routine safety testing, pathology, customized sample collection kits, advanced sample tracking), and Toxicology Services delivered through the wholly-owned DRUGSCAN brand (drug monitoring, workplace testing, reference lab testing).
ACM's underlying technology centers on a harmonized laboratory platform deployed across global sites for consistency in chemistry, hematology, urinalysis, flow cytometry, and immunology testing, wrapped by proprietary client-facing tools: LabStar (single-database data management across global locations), ACM QuikReport™ (real-time client reporting portal), and Advanced Sample Tracking Services for specimen chain-of-custody. Regulatory credentials include CAP accreditation (notably at the Singapore hub) and compliance with CAP/CLIA, GDPR, and the EU-U.S. Data Privacy Framework.
The business model is professional services / contract-based B2B: each clinical trial program is customized to protocol, with pricing quoted per engagement rather than published. Go-to-market is enterprise field sales targeting pharma/biotech sponsors directly, supplemented by a DRUGSCAN franchise selling toxicology and medication monitoring to healthcare providers. The company is privately held with no disclosed funding rounds or external investors, and is affiliated with (rather than owned by) Rochester Regional Health.
ACM Global firmographics
Firmographics- Name
- ACM Global
- Legal name
- ACM Medical Laboratory, Inc. dba ACM Global Laboratories
- Website
- https://acmgloballab.com
- Company type
- Private
- Founded year
- 1975
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- ACM Global Laboratories is a privately held, US-headquartered central laboratory founded in 1975, providing customized clinical trial testing, bioanalytical, and toxicology (DRUGSCAN) services to pharmaceutical and biotech sponsors across 65+ countries.
- Ownership category
- akta.pro rank
Where ACM Global is headquartered
LocationHeadquarters
- HQ city
- Rochester
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
ACM Global business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Central Laboratory Testing Services: ACM Global Laboratories provides central lab services for clinical trial programs, including routine and esoteric testing, bioanalytical services, biomarker testing, flow cytometry, pathology, and radiopharmaceutical services. Services are customized per clinical trial program and billed on a project/contract basis.
- Bioanalytical Services: Comprehensive bioanalytical testing including PK bioanalysis, large molecule bioanalysis, pharmacodynamic biomarker analysis, controlled substance analysis, novel drug delivery systems, nicotine research, and cannabinoid testing for drug development programs.
- Toxicology Services (DRUGSCAN): Toxicology laboratory testing services including drug monitoring, workplace testing, and reference laboratory testing, delivered through the DRUGSCAN brand with a 30-year track record in medication monitoring solutions.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
ACM Global product offering
Product offeringCore offering
ACM Global Laboratories provides customized central laboratory testing services for clinical trial programs, including routine and esoteric safety testing, biomarker analysis, flow cytometry, pathology, radiopharmaceutical testing, and bioanalytical services such as PK analysis, large molecule bioanalysis, and pharmacodynamic biomarker assessment. Toxicology and drug monitoring services are delivered through the DRUGSCAN brand, with proprietary platforms (LabStar and ACM QuikReport) enabling seamless global data management.
Product overview
ACM Global Laboratories is a global clinical trial testing services company offering three interconnected service lines: (1) Bioanalytical Services including ACM Bioanalysis, Large Molecule Bioanalysis, Advanced PK/Pharmacokinetic Services, Pharmacodynamic Biomarker Analysis, Controlled Substance Analysis, Novel Drug Delivery Systems, Nicotine Research, and Cannabinoid Testing; (2) Central Lab Services encompassing Clinical Trial Testing, Rescue Studies, Expedite Studies, Biomarker Testing, Flow Cytometry Testing, Radiopharmaceutical Services, Routine Safety Testing, Customized Sample Collection Kits, Advanced Sample Tracking Services, COVID-19 Research Studies, and Pathology Services; and (3) Toxicology Services through the acquired DRUGSCAN brand covering Drug Monitoring, Workplace Testing, and Reference Laboratory Testing. Client-facing platforms include LabStar and ACM QuikReport for reporting and portal access. The company operates wholly-owned facilities in the United States (Rochester, NY), Europe (York, UK), Singapore, and India (Mumbai), supporting clinical trials in more than 65 countries.
Differentiator
Problem solved
Functional benefit
Brands
- DRUGSCAN: Best-in-breed toxicology laboratory testing company with 30-year track record delivering innovative medication monitoring solutions to healthcare providers across the United States
- DSI Medical
- ACM Bioanalysis
- ACM Central Lab Services
- ACM Toxicology Services
- ACM QuikReport
- LabStar
Products and services
- ACM Central Lab Services Provides customized central laboratory services for clinical trial programs, including routine safety testing, biomarker testing, flow cytometry, pathology, radiopharmaceutical services, customized sample collection kits, and advanced sample tracking, with scientific experts and project managers helping sponsors make data-driven decisions from inception to completion.
- ACM Bioanalysis Provides assay method development and validation for the quantification of drugs, metabolites, and biomarkers in biological samples, supporting PK bioanalysis, large molecule bioanalysis, pharmacodynamic biomarker analysis, controlled substance analysis, novel drug delivery systems, nicotine research, and cannabinoid testing for drug development programs.
- DRUGSCAN (Toxicology Services) Toxicology laboratory testing services for healthcare providers, including drug monitoring, workplace drug testing, and reference laboratory testing, delivered through the DRUGSCAN brand with a 30-year track record in medication monitoring solutions.
Companies that use ACM Global
Customer profileSegments2 records
Ideal customer profiles2 records
ACM Global technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
ACM Global partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- DRUGSCANcoreDRUGSCAN is a best-in-breed toxicology laboratory testing company with a 30-year track record of delivering innovative medication monitoring solutions to healthcare providers across the United States. ACM Global Laboratories includes DRUGSCAN under its Toxicology Services umbrella, offering drug monitoring, workplace testing, and reference laboratory testing services.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
ACM Global competitors and assessment
Company assessmentDirect peers
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO with central laboratory and bioanalytical capabilities, competing with ACM for mid-sized pharma and biotech central lab programs.
- Eurofins Central Laboratory: Eurofins Central Laboratory provides global central lab and specialty testing services for clinical trials, with a comparable multi-region footprint and routine/specialty testing menu.
- ICON Central Laboratories: ICON plc runs a global central laboratory network serving clinical trials with bioanalytical, biomarker, and specialty testing services that closely mirror ACM Global's offerings.
- Q² Solutions: Q² Solutions is a leading clinical trial central laboratory services joint venture between IQVIA and Quest Diagnostics, offering end-to-end central lab, bioanalytical, and biomarker services comparable to ACM's portfolio.
- Labcorp Central Laboratories (Fortrea): Fortrea (spun out of Labcorp) is one of the largest global central laboratory and clinical trial services providers, directly competing with ACM Global Laboratories for multi-region Phase II/III central lab contracts.
- Medpace Reference Laboratories: Medpace operates a global central laboratory with bioanalytical and biomarker services supporting its CRO business, offering a comparable mid-sized full-service model to ACM.
Broad incumbents
- Charles River Laboratories: Charles River is a large CRO and lab services provider offering central lab, bioanalytical, and safety assessment services across a broader discovery-to-clinical continuum that overlaps with ACM's trial support work.
- IQVIA Laboratories: IQVIA operates the world's largest CRO platform and includes significant central lab capabilities through Q² Solutions and bioanalytical services, competing with ACM across multiple service lines.
- PPD Central Laboratory (Thermo Fisher): PPD, part of Thermo Fisher Scientific, is a global CRO with central laboratory services and bioanalytical capabilities that compete with ACM on large multi-region clinical trial programs.
Emerging players
- BioAgilytix Labs: BioAgilytix is a bioanalytical-focused lab with large molecule and biomarker capabilities serving clinical trials, partially overlapping with ACM's ACM Bioanalysis and biomarker service lines.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
ACM Global social profiles
Digital presenceACM Global financial estimates
Financial estimateRevenue estimate
Valuation estimate
ACM Global leadership team
Management profileNumber of profiles
Profiles1 record
ACM Global subsidiaries and ownership
Company hierarchySubsidiaries2 records
ACM Global funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ACM Global M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ACM Global
What does ACM Global do?
ACM Global Laboratories provides customized central laboratory testing services for clinical trial programs, including routine and esoteric safety testing, biomarker analysis, flow cytometry, pathology, radiopharmaceutical testing, and bioanalytical services such as PK analysis, large molecule bioanalysis, and pharmacodynamic biomarker assessment. Toxicology and drug monitoring services are delivered through the DRUGSCAN brand, with proprietary platforms (LabStar and ACM QuikReport) enabling seamless global data management.
Is ACM Global a public or private company?
ACM Global is a private company. It is classified as unknown and is currently operating.
When was ACM Global founded?
ACM Global was founded in 1975. It employs 501 to 1,000 people.
Where is ACM Global based?
ACM Global is headquartered in Rochester, United States, in the North America region.
How does ACM Global make money?
Three revenue lines are on record. Central Laboratory Testing Services are the primary driver. The others are bioanalytical Services and toxicology Services (DRUGSCAN).
Who are ACM Global's main competitors?
Direct peers on record are Worldwide Clinical Trials, Eurofins Central Laboratory, ICON Central Laboratories, Q² Solutions, Labcorp Central Laboratories (Fortrea) and Medpace Reference Laboratories. Broad incumbents are Charles River Laboratories, IQVIA Laboratories and PPD Central Laboratory (Thermo Fisher). BioAgilytix Labs is listed as an emerging player.
Does ACM Global have an API?
No public API is recorded for ACM Global.